Department of Obstetrics and Gynecology, Suzhou Ninth People's Hospital, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, 215200, China.
Jiangsu Institute of Hematology, The First Affiliated Hospital and Collaborative Innovation Center of Hematology, Key Laboratory of Thrombosis and Hemostasis of National Health Commission, Suzhou, 215006, China.
BMC Pregnancy Childbirth. 2024 Oct 21;24(1):687. doi: 10.1186/s12884-024-06887-0.
Cesarean scar pregnancy (CSP), a distinct form of ectopic pregnancy, presents challenges in effective management. It is categorized into three subtypes according to the location of placental implantation and the thickness of the myometrium at the uterine scar. Nevertheless, the optimal choice of treatment modalities for these subtypes remains largely unexamined.
In this retrospective analysis, we investigated the cases of 130 patients diagnosed with CSP who underwent diverse treatment approaches, namely ultrasound-guided dilation and curettage (D&C), hysteroscopic surgery alone or in combination with laparoscopic surgery (HCoLC), or uterine artery embolization (UAE) followed by curettage. Clinical data were meticulously retrieved from medical records and follow-up data, and a comparative analysis of relevant indicators was carried out across the different CSP subtypes.
From January 2017 to December 2021, 35 patients underwent D&C, 85 underwent HCoLC, and 10 received UAE as a pretreatment. In the D&C group, the success rates for Type I and Type II CSP were 64.29% (18/28) and 14.28% (1/7), respectively. Significant differences were observed between the success and failure groups in terms of gestational sac size and clinical classification. Compared to Type I CSP, Type II CSP exhibited significantly longer surgical durations and higher hospitalization costs (P < 0.05). Three patients classified as Type III underwent simultaneous hysteroscopic evacuation of cesarean scar pregnancy and laparoscopic repair of the cesarean scar defect, achieving a 100% success rate in their initial treatment. HCoLC showed no significant differences in surgical duration and hospitalization costs but had higher success rates and shorter hospital stays compared to the D&C and UAE groups (P < 0.05). The UAE group had significantly longer surgical durations, higher hospitalization costs, and a higher incidence of postoperative complications (P < 0.05). However, these factors did not result in improved surgical success rates.
The classification of CSP and the measurement of gestational sac are of crucial importance in determining the most appropriate surgical intervention strategy. For patients diagnosed with Type I CSP, D&C and hysteroscopy are reliable treatment choices. In cases with larger gestational sacs or Type II CSP, hysteroscopy, either alone or in combination with laparoscopy, is regarded as a reliable and effective treatment approach. In patients with type III CSP, lesion excision with uterine repair is the recommended treatment.
剖宫产瘢痕妊娠(CSP)是一种特殊类型的异位妊娠,在有效管理方面存在挑战。根据胎盘着床位置和剖宫产瘢痕处子宫肌层的厚度,可将其分为三型。然而,对于这些类型,最佳的治疗方式选择仍未得到充分研究。
本回顾性分析纳入了 130 例接受不同治疗方法的 CSP 患者,包括超声引导下的扩张刮宫术(D&C)、单纯宫腔镜手术或联合腹腔镜手术(HCoLC)、子宫动脉栓塞术(UAE)后刮宫术。我们从病历和随访数据中仔细提取了临床数据,并对不同 CSP 亚型的相关指标进行了比较分析。
2017 年 1 月至 2021 年 12 月,35 例患者接受了 D&C,85 例接受了 HCoLC,10 例接受了 UAE 预处理。在 D&C 组中,Ⅰ型和Ⅱ型 CSP 的成功率分别为 64.29%(28/43)和 14.28%(7/49)。在孕囊大小和临床分类方面,成功组和失败组之间存在显著差异。与Ⅰ型 CSP 相比,Ⅱ型 CSP 的手术时间更长,住院费用更高(P<0.05)。3 例Ⅲ型患者行剖宫产瘢痕妊娠宫腔镜下清除术联合剖宫产瘢痕缺损腹腔镜修补术,初始治疗成功率达 100%。与 D&C 和 UAE 组相比,HCoLC 组的手术时间和住院费用无显著差异,但成功率更高,住院时间更短(P<0.05)。UAE 组的手术时间更长,住院费用更高,术后并发症发生率更高(P<0.05)。然而,这些因素并未提高手术成功率。
CSP 的分类和孕囊的测量对于确定最合适的手术干预策略至关重要。对于诊断为Ⅰ型 CSP 的患者,D&C 和宫腔镜是可靠的治疗选择。对于孕囊较大或Ⅱ型 CSP 的患者,宫腔镜单独或联合腹腔镜是可靠有效的治疗方法。对于Ⅲ型患者,建议进行病灶切除和子宫修复。